{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/a4c5de36-8260-4222-8e38-ff997dc73436/67645264a977962b2e7b9bb1?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Activist investing, Hollywood Bowl & US markets: The Companies and Markets Show","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61b9b44742e856e989985776/1734627888613-6c3d93eb-acb7-41dd-8273-50c355a393e1.jpeg?height=200","description":"<p>We begin the year's final podcast discussing <a href=\"https://www.investorschronicle.co.uk/content/c3688d84-8bcf-502a-ab6e-606ba6dc8c97\" rel=\"noopener noreferrer\" target=\"_blank\">activist investor Saba Capital</a>. Funds editor Dave Baxter explores the impact of its demand to remove the boards of seven investment trusts and what investors should do if the changes go ahead.</p><p><br></p><p>It’s then onto <a href=\"https://www.investorschronicle.co.uk/content/0b63c432-551a-5e04-aca8-c4355a04431f\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>Hollywood Bowl’s (BOWL) </strong>results</a>. The company reported a 7 per cent rise in revenue, but shares still fell 10 per cent. Michael Fahy explains what caused the fall as well as the business's valuation.</p><p><br></p><p>Last up, our US-based writer Arthur Sants joins in the studio. From the recent market sell-off after comments from the Fed to the Magnificent Seven stocks, investors can find out what to expect from American markets in the coming year. </p><p><br></p><p><strong>Timestamps&nbsp;</strong></p><p>1:17 Saba Capital</p><p>9:31 Hollywood Bowl</p><p>17:43 The US</p><p><br></p><p>Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit <a href=\"http://www.investorschronicle.co.uk/podcasttrial\" rel=\"noopener noreferrer\" target=\"_blank\">www.investorschronicle.co.uk/podcasttrial</a>&nbsp;</p><p>*After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.</p>","author_name":"Investors' Chronicle"}